Judge won’t let Pfizer rid itself of inherited fen-phen scourge

Judge won't let Pfizer rid itself of inherited fen-phen scourge



Category: Fen Phen

More Info: Defective Drugs

Pfizer just can’t get rid of the specter of fen-phen. Fifteen years after the diet drug was removed from the market over serious health concerns, litigation lingers and the drugmaker’s move to kill that off fell short yesterday.

Pfizer has reserved $21 billion for fen-phen litigation over the years but hoped to have remaining suits dismissed. But a judge in Philadelphia, where most of the suits are consolidated, wasn’t buying it. He said plaintiffs can use studies from experts that indicate that fen-phen can instigate primary pulmonary hypertension, even more than a decade after consumers stopped taking the appetite suppressant. Pfizer tells Bloomberg that it is weighing its legal options.

Pfizer bought the problem when it acquired the drug’s developer Wyeth in 2009, 12 years after fen-phen was banned in the U.S. More than 6 million prescriptions had been written when it was on the market, Bloomberg says, and at one time there were more than 175,000 claims that the combo diet drug had caused health problems, sometimes leading to early deaths.

Wyeth originally set up a $1.3 billion fund in 2004 to cover the potential losses, but over the years that escalated as litigation and potential liability grew. By the time Pfizer entered the picture, the fund was at $21.1 billion.

Of course, lingering litigation is common to many drugmakers. Pfizer in June, for example, reported in a financial filing that it had paid out nearly $900 million on about 6,000 injury cases related to the hormone replacement Prempro and had 

Continue reading...

See the original article here: https://www.fiercepharma.com/regulatory/judge-won-t-let-pfizer-rid-itself-of-inherited-fen-phen-scourge


About TriMark Legal Funding

TriMark Legal Funding was founded in 2003 and is one of America's leading national lawsuit funding companies. TriMark provides pre-settlement funding and post-settlement funding, sometimes called 'lawsuit loans', to injured plaintiffs throughout the United States. We offer funding on hundreds of different types of legal claims including personal injury loans, employment litigation funding, work injury accident loans, workers compensation loans, mass tort litigation funding, and multidistrict litigation funding.

We also provide immediate inheritance advance funding for heirs and beneficiaries, as well as attorney funding and law firm financing for legal practices.

Personal Injury LawsuitsMass Torts

Click here to see the original article.

* Word-Use Disclaimer

Legal funding is not a loan. It is the non-recourse purchase of an equitable lien in a plaintiffs’ legal claim. Words such as ‘loans,’ ‘lending,’ ‘borrow,’ etc., are used for search and marketing purposes only.
More info

TriMark Legal Funding LLC
1056 Green Acres Rd #102
Eugene, OR 97408